ALT Altimmune, Inc.

ALT Altimmune, Inc.

Healthcare · Biotechnology

Market read

POC $2.97 · VWAP $3.63 · -39.4% vs 12m avg buyer

collapse vol: normalgaps: stablechurn: quiet as of

Insiders quiet 0 buy / 0 sell · Form 4, 90d

Coverage

1 watchlist

Watchlists @peptide-economy

ALT Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist ALT belongs to, members best 30-day change first — ALT highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

Next earnings ALT reports in 19 days Nov 5

Last report Aug 12

Reported EPS $-0.12 versus analyst consensus of $-0.12 (+4.0%).

full note →

Against street estimates

How ALT's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 10 quarters · newest report Aug 12 · projection Oct 16

Result
Aug 12 -0.12-0.12+4.0%Beat
May 13 -0.25-0.18+28.0%Beat
Mar 5 -0.24-0.27-11.2%Miss
Nov 6 '25 -0.27-0.21+21.0%Beat
Aug 12 '25 -0.32-0.27+15.8%Beat
May 13 '25 -0.34-0.26+23.9%Beat
Feb 27 '25 -0.34-0.33+1.5%In line
Nov 12 '24 -0.36-0.32+10.5%Beat